Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 54.4% in May

Terumo Corp. (OTCMKTS:TRUMY) was the target of a significant decline in short interest in May. As of May 15th, there was short interest totaling 14,067 shares, a decline of 54.4% from the April 30th total of 30,823 shares. Based on an average trading volume of 679,301 shares, the short-interest ratio is currently 0.0 days. Approximately 0.0% of the company’s stock are short sold.

Terumo Stock Down 0.7%

Shares of TRUMY traded down $0.10 during trading hours on Friday, hitting $15.04. The company had a trading volume of 103,669 shares, compared to its average volume of 260,081. The stock has a market capitalization of $22.19 billion, a price-to-earnings ratio of 24.66 and a beta of 0.62. The firm has a fifty day moving average price of $13.45 and a 200-day moving average price of $13.90. Terumo has a 52-week low of $12.08 and a 52-week high of $19.60. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.89 and a current ratio of 1.51.

Terumo (OTCMKTS:TRUMY) last released its quarterly earnings data on Friday, May 15th. The company reported $0.11 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.11. The business had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.84 billion. Terumo had a net margin of 12.09% and a return on equity of 9.35%. On average, equities research analysts forecast that Terumo will post 0.63 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Zacks Research raised shares of Terumo to a “hold” rating in a research note on Thursday, April 9th. Nomura upgraded Terumo to a “hold” rating in a research note on Tuesday, February 24th. Two analysts have rated the stock with a Hold rating, According to data from MarketBeat, the company currently has an average rating of “Hold”.

Terumo Company Profile

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.